Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleMesoblast acquires Osiris' stem cell business.AuthorsWaltz, EmilyAbstractThe article reports on acquiring of regenerative medicine firm Osiris Therapeutics Inc.'s business by regenerative medicine firm Mesoblast Ltd. and informs that signature product of Osiris named Prochymal was offloaded in October 2013.SubjectsOSIRIS Therapeutics Inc.; MESOBLAST Ltd.PublicationNature Biotechnology, 2013, Vol 31, Issue 12, p1061ISSN1087-0156Publication typeArticleDOI10.1038/nbt1213-1061